Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and raises the price target from $3.25 to $5.
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and raises the price target from $3.25 to $5.